Irish Medicines Board Act 1995 (No. 29 of 1995).

The Irish Medicines Board Act of 1995 outlines the establishment and functions of the Irish Medicines Board. This Act aims to regulate the manufacture, production, preparation, importation, advertisement, sale, and distribution of medicinal and cosmetic products. It also provides for the dissolution of the National Drugs Advisory Board, transferring its functions to the newly established Irish Medicines Board. The Act includes provisions for the Board's structure, including its chairperson, members, and advisory committees, as well as its financial aspects such as fees, charges, grants, and borrowing. Additionally, it addresses the Board's duties, reporting requirements, and the handling of assets, liabilities, and legal proceedings from the former Board.
The Act includes specific provisions for the regulation of veterinary medicinal products. These provisions ensure that veterinary drugs are safe, effective, and of high quality. The Act outlines the responsibilities of the Irish Medicines Board in overseeing the manufacture, distribution, and sale of these products, similar to its role with human medicinal products. This includes the assessment and approval of veterinary drugs, monitoring their use, and ensuring compliance with relevant standards and regulations.